13G Filing: VenBio Select Advisor and Mirati Therapeutics Inc. (MRTX)

Page 7 of 7

Page 7 of 7 – SEC Filing

SIGNATURES

After reasonable
inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in
this statement is true, complete and correct.

DATE: October 3, 2017

venBio Select Advisor LLC
/s/ Scott Epstein
Name: Scott Epstein
Title: Chief Financial Officer & Chief
Compliance Officer

/s/ Behzad Aghazadeh

BEHZAD AGHAZADEH

Follow Mirati Therapeutics Inc. (NASDAQ:MRTX)

Page 7 of 7